Yahoo Search Busca da Web

Resultado da Busca

  1. Há 1 dia · Oatly Revenue. Oatly had revenue of $786.86M in the twelve months ending March 31, 2024, with 4.68% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $199.16M with 1.79% year-over-year growth. In the year 2023, Oatly had annual revenue of $783.35M with 8.46% growth. Revenue (ttm)

  2. 24 de mai. de 2024 · Procter & Gamble Revenue. Procter & Gamble had revenue of $84.06B in the twelve months ending March 31, 2024, with 3.82% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $20.20B with 0.63% year-over-year growth. In the fiscal year ending June 30, 2023, Procter & Gamble had annual revenue of $82.01B with 2.27% growth.

  3. 10 de mai. de 2024 · Zillow Group Revenue. Zillow Group had revenue of $2.01B in the twelve months ending March 31, 2024, with 6.03% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $529.00M with 12.79% year-over-year growth. In the year 2023, Zillow Group had annual revenue of $1.95B, a decrease of -0.66%. Revenue (ttm)

  4. 16 de mai. de 2024 · The meaning of OVER THE YEARS is during several/some/many years. How to use over the years in a sentence.

  5. 18 de mai. de 2024 · Rockstar Stock Price. Rockstar/Take-Two Interactive’s stock price has risen 380% in the last five years. This values Take2 at $20 billion, compared to its current stock price of around $170. According to Stock Rover, Take-Two Interactive is overvalued because its current margin of safety is -17 %.

  6. 9 de mai. de 2024 · The operating revenue of CYIENT DLM LIMITED is in the range of Over INR 500 cr for the financial year ending on 31 March, 2023. What is the increase in EBITDA of CYIENT DLM LIMITED since last year? The EBITDA of CYIENT DLM LIMITED has increased by 4.45 % over the previous year.

  7. 10 de mai. de 2024 · PTC Therapeutics had revenue of $927.56M in the twelve months ending March 31, 2024, with 20.39% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $210.12M, a -4.66% decrease year-over-year. In the year 2023, PTC Therapeutics had annual revenue of $937.82M with 34.20% growth. Revenue (ttm)